Clinical trials: Minimum Effective Dose

Asthma

Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children

• Terminated
• Age: 3 to 6 years
• Phase 4

To determine whether addition of ipratropium bromide to salbutamol nebulisations produces significantly greater bronchodilation in young children presenting to an emergency department with an acute attack of asthma

Trial name

NCT02235428

Testing

Ipratropium bromide, Salbutamol

Volunteers

3 people

Sponsor

Boehringer Ingelheim